When to Get Shingles Vaccine After Having Shingles
You should receive the Shingrix vaccine at least 2 months after your shingles episode has resolved and symptoms have subsided. 1
Rationale for the 2-Month Waiting Period
The 2-month minimum interval is based on documented evidence showing that the shortest interval between an initial shingles episode and recurrence is approximately 2 months 1. This recommendation balances the need to:
- Allow the acute infection to fully resolve
- Avoid potential interference with vaccine immunogenicity during active viral replication
- Provide timely protection against recurrence
Why Vaccination After Shingles Is Critical
Having had shingles does NOT protect you from getting it again—in fact, you remain at significant risk for recurrence:
- At 2 years post-shingles: 2.5% cumulative recurrence rate
- At 4 years: 4.8%
- At 6 years: 6.6%
- At 10 years: 10.3% 1
These high recurrence rates strongly support vaccination even after a prior shingles episode.
Practical Implementation
Timing options:
- Minimum wait: 2 months after acute symptoms resolve 1
- Acceptable range: Some guidelines suggest waiting up to 1 year is acceptable, though this may unnecessarily delay protection 1
The FDA label for Shingrix does not specify a mandatory waiting period after shingles 2, but clinical guidelines consistently recommend the 2-month minimum based on recurrence data.
Dosing Schedule After Shingles
Once you begin vaccination:
- Standard schedule: Two doses given 2-6 months apart 3, 2
- For immunocompromised patients: Two doses can be given 1-2 months apart if a shorter schedule is beneficial 2
Important Caveats
Do not confuse this with other vaccination scenarios:
- If you previously received the older live vaccine (Zostavax/ZVL), wait at least 2 months before switching to Shingrix 3
- The 2-month waiting period applies specifically to recovery from active shingles infection, not to intervals between vaccine doses
Common pitfall: Some international guidelines recommend longer waiting periods (up to 1 year in Canada, Ireland, and Australia) 1, but the most recent 2024 consensus guideline supports the 2-month minimum as sufficient, allowing earlier protection without compromising safety or efficacy.